Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

EMCTO 2011 – European Multidisciplinary Conference in Thoracic Oncology

European multidisciplinary conference thoracic oncology 2011 resources
Start date
24 Feb 2011
End date
26 Feb 2011
Lugano, Switzerland

From 24-26 February 2011 international members of the lung cancer community convened in Lugano for the 2nd European Multidisciplinary Conference in Thoracic Oncology (EMCTO).

EMCTO is created in partnership with a multidisciplinary, authoritative group of European partners in thoracic oncology:ESMO, ESTRO, ESTS, ERS. An  exceptionally prepared educational programme included sessions on novelties and updates in diagnostics in lung cancer, integration of staging procedures, presentation of common cases, optimal care for patients with different thoracic malignancies, treatment of pulmonary metastases to local therapy, and a panel discussion on requirements for thoracic oncology centres.

Access ECMTO 2011 Abstract book

Access the EMCTO 2011 Webcasts

The scientific committee also presented the ESMO Guidelines for the Diagnosis, Treatment and Follow up on NSCLC” developed through the first European Consensus Conference on different aspects and challenging issues in this disease that encompass many entities on the basis of diversified pathobiology.

The conference was an excellent opportunity to interact with expert speakers and international peers while learning about integrated approaches to diagnosis and treatment.

EMCTO offers an educational interaction for physicians of all medical disciplines dealing with lung cancer and other thoracic malignancies. The number of diagnostic and therapeutic options for patients with thoracic malignancies has markedly increased, allowing for an individualised approach based on the clinical situation and molecular characteristics of the tumour. How to best select among these options for the benefit of the patients within an integrative treatment approach will be at the core of the conference. 

Rolf Stahel

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings
  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.